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Abstract
Named entity recognition (NER) is the very
first step in the linguistic processing of any
new domain. It is currently a common pro-
cess in BioNLP on English clinical text. How-
ever, it is still in its infancy in other ma-
jor languages, as it is the case for Spanish.
Presented under the umbrella of the PHAR-
MACONER shared task, this paper describes
a very simple method for the annotation and
normalization of pharmacological, chemical
and, ultimately, biomedical named entities in
clinical cases. The system developed for the
shared task is based on limited knowledge,
collected, structured and munged in a way that
clearly outperforms scores obtained by sim-
ilar dictionary-based systems for English in
the past. Along with this recovering of the
knowledge-based methods for NER in subdo-
mains, the paper also highlights the key con-
tribution of resource-based systems in the val-
idation and consolidation of both the annota-
tion guidelines and the human annotation prac-
tices. In this sense, some of the authors dis-
coverings on the overall quality of human an-
notated datasets question the above-mentioned
‘official’ results obtained by this system, that
ranked second (0.91 F1-score) and first (0.916
F1-score), respectively, in the two PHARMA-
CONER subtasks.
1 Introduction
Named Entity Recognition (NER) is considered a
necessary first step in the linguistic processing of
any new domain, as it facilitates the development
of applications showing co-occurrences of domain
entities, cause-effect relations among them, and,
∗This paper should have been published in the Proceed-
ings of the 5th Workshop on BioNLP Shared Tasks. Unfor-
tunately, due to their complete lack of funding, the authors
could not afford the registration fees, a mandatory expense
for a contribution to be published in the aforementioned pro-
ceedings.
eventually, it opens the (still to be reached) pos-
sibility of understanding full text content. On
the other hand, Biomedical literature and, more
specifically, clinical texts, show a number of fea-
tures as regards NER that pose a challenge to NLP
researchers (Cohen and Demner-Fushman, 2014):
(1) the clinical discourse is characterized by being
conceptually very dense; (2) the number of dif-
ferent classes for NEs is greater than traditional
classes used with, for instance, newswire text; (3)
they show a high formal variability for NEs (ac-
tually, it is rare to find entities in their “canoni-
cal form”); and, (4) this text type contains a great
number of ortho-typographic errors, due mainly to
time constraints when drafted.
Many ways to approach NER for biomedical lit-
erature have been proposed, but they roughly fall
into three main categories: rule-based, dictionary-
based (sometimes called knowledge-based) and
machine-learning based solutions. Tradition-
ally, the first two approaches have been the
choice before the availability of Human Annotated
Datasets (HAD), albeit rule-based approaches re-
quire (usually hand-crafted) rules to identify terms
in the text, while dictionary-based approaches
tend to miss medical terms not mentioned in
the system dictionary (Rebholz-Schumann et al.,
2011). Nonetheless, with the creation and
distribution of HAD as well as the develop-
ment and success of supervised machine learn-
ing methods, a plethora of data-driven approaches
have emerged —from Hidden Markov Models
(HMMs) (Ephraim, 2002), Support Vector Ma-
chines (SVMs) (Habib and Kalita, 2010) and Con-
ditional Random Fields (CRFs) (He and Kayaalp,
2008), to, more recently, those founded on neu-
ral networks (Armengol-Estape´ et al., 2019). This
fact has had an impact on knowledge-based meth-
ods, demoting them to a second plane. Besides,
this situation has been favoured by claims on the
uselessness of gazetteers for NER in, for example,
Genomic Medicine (GM), as it was suggested by
Cohen and Demner-Fushman (2014, p. 26):
One of the findings of the first BioCre-
ative shared task was the demonstration
of the long-suspected fact that gazetteers
are typically of little use in GM.
Although one might think that this view could
strictly refer to the subdomain of GM and to
the past —BioCreative I was a shared task
held back in 2004—, we can still find similar
claims today, not only referred to rule-based and
dictionary-based methods, but also to stochastic
ones (Armengol-Estape´ et al., 2019).
In this paper, in spite of previous statements,
we present a system that uses rule-based and
dictionary-based methods combined (in a way
we prefer to call resource-based). Our final
goals in the paper are two-fold: on the one
hand, to describe our system, developed for
the PHARMACONER shared task1, dealing with
the annotation of some of the NEs in health
records (namely, pharmacological, chemical and
biomedical entities) using a revisited version of
rule- and dictionary-based approaches; and, on
the other hand, to give pause for thought about the
quality of datasets (and, thus, the fairness) with
which systems of this type are evaluated, and to
highlight the key role of resource-based systems
in the validation and consolidation of both the
annotation guidelines and the human annotation
practices.
In section 2, we describe our initial resources
and explain how they were built, and try to address
the issues posed by features (1) and (2) above.
Section 3 depicts the core of our system and the
methods we have devised to deal with text features
(3) and (4). Results obtained in PHARMACONER by
our system are presented in section 4. Section 5
details some of our errors, but, most importantly,
focusses on the errors and inconsistencies found
in the evaluation dataset, given that they may shed
doubts on the scores obtained by any system in the
competition. Finally, we present some concluding
remarks in section 6.
1
http://temu.bsc.es/pharmaconer/
2 Resource building
As it is common in resource-based system de-
velopment, special effort has been devoted to the
creation of the set of resources used by the sys-
tem. These are mainly two —a flat subset of the
SNOMED CT medical ontology2 , and the library
and a part of the contextual regexp grammars de-
veloped by Sa´nchez-Leo´n (2018) for a previous
competition on abbreviation resolution in clinical
texts written in Spanish. The process of creation
and/or adaptation of these resources is described
in this section.
2.1 SNOMED CT
Although the competition proposes two differ-
ent scenarios, in fact, both are guided by the
SNOMED CT ontology —for subtask 1, entities
must be identified with offsets and mapped to
a predefined set of four classes (PROTEINAS,
NORMALIZABLES, NO NORMALIZABLES and
UNCLEAR); for subtask 2, a list of all SNOMED CT
IDs (sctid) for entities occurring in the text must be
given, which has been called concept indexing by
the shared task organizers3. Moreover, PHARMA-
CONER organizers decided to promote SNOMED
CT substance IDs over product, procedure or other
possible interpretations also available in this medi-
cal ontology for a given entity. This selection must
be done even if the context clearly refers to a dif-
ferent concept, according to the annotation guide-
lines4 (henceforth, AnnotGuide) and the praxis.
Finally, PROTEINAS is ranked as the first choice
for substances in this category.
These previous decisions alone on the part of
the organizers greatly simplify the task at hand,
making it possible to build (carefully compiled)
subsets of the entities to be annotated. This is
a great advantage over open domain NER, where
(like in GM) the texts may contain an infinite (and
very creative indeed) number of NEs. For clinical
cases, although the NE density is greater, there ex-
ist highly structured terminological resources for
the domain. Moreover, the set of classes to use
2From https://browser.ihtsdotools.org/.
3In the train+dev datasets, only 17 of the PROTEINAS
(‘proteins’) and NORMALIZABLES (‘standardizable’) enti-
ties have an ID not in the SNOMED CT ontology. Besides,
just 40 out of 5,615 annotations —not taking into account
the class UNCLEAR, which is not considered for the sys-
tem evaluation— are tagged as NO NORMALIZABLES (‘non
standardizable’), many of them due to the fact that they in-
clude elliptical constructions.
4
https://bit.ly/2qxofgd, p. 4.
in the annotation exercise for subtask 1 has been
dramatically cut down by the organizers.
With the above-mentioned initial constraints in
mind, we have painstakingly collected, from the
whole set of SNOMED CT terms, instances of en-
tities as classified by the human annotators in
the datasets released by the organizers and, when
browsing the SNOMED CT web version, we have
tried to use the ontological hierarchical relations
to pull a complete class down from SNOMED
CT. This way, we have gathered 80 classes —
from lipids to proteins to peptides or peptide hor-
mones, from plasminogen activators to dyes to
drugs or medicaments—, that have been arranged
in a ranked way so as to mimic human annota-
tors choices5. The number of entities so collected
(henceforth, ‘primary entities’) is 51,309.
2.2 Contextual regexp grammars
Some of the entities to be annotated, specially
those in abbreviated form, are ambiguous without
a context. This is the case, for instance, of PCR,
whose expanded forms are (among other mean-
ings; we use only English expanded forms) ‘reac-
tive protein c’, ‘polymerase chain reaction’, ‘car-
diorespiratory arrest’. In order to deal with these
cases, we use a contextual regexp rule system with
a lean and simple rule formalism previously de-
veloped (Sa´nchez-Leo´n, 2018). As an exemplifi-
cation, we include one rule to deal with one of the
cases of the preceeding ambiguity:
b:[il::bioquı´mica|en sangre|hemoglobina|
hemograma|leucocit|para´sito|plaqueta|
prote.na|recuento|urea] - [PCR] - >
[m=proteı´na]
A rule has a left hand side (LHS) and a right
hand side (RHS). There is a focus in the LHS
(PCR, within dashes) and a left and right context
(that may be empty). When the left context in-
cludes a b: (like in this case), it indicates ei-
ther left or right context. The words in the con-
text can take other qualifiers —in this case, the
matching will be case insensitive (i to the left of
bioquı´mica) and local (l), which means the
disjunction of words and/or stems can be found
in a distance of 40 characters (this can be modifi-
fied by the user). Hence, the rule applies, selecting
the proteı´na expansion (in RHS) of PCR if any
of the words/stems specified as local context (40
5Note that we have gathered the complete set of medical
terms included in SNOMED CT, but, for the purpose of this
shared task, we only use a subset of it.
chars maximum) is matched either to the left or
right of the focus term (which is usually an abbre-
viation).
With no tweaking at all for the datasets in PHAR-
MACONER competition, the system annotates cor-
rectly 18 out of 20 occurrences of PCR in the test
dataset (a precision of 0.9)6.
This component of the system is important be-
cause, only when the previous abbreviation is ex-
panded as the first string (that of a protein name),
it must be annotated, according to the AnnotGuide.
The same ambiguity happens with Cr, which may
mean ‘creatinine’ or ‘chrome’7. These expansions
are both NORMALIZABLES, but, obviously, their
sctid is different.
The system currently uses 104 context rules,
only for abbreviations and acronyms in the clin-
ical cases. These rules, contrary to what is com-
monly referred in the biomedical processing lit-
erature (Armengol-Estape´ et al., 2019), do not re-
quire a special domain knowledge (none of the au-
thors do have it) and can be written, most of the
times, in a very straightforward way in the formal-
ism briefly described above.
3 Development
In general, dictionary-based methods rely on strict
string matching over a fixed set of lexical entries
from the domain. This is clearly insufficient to
deal with non-canonical linguistic forms of NEs as
used in clinical texts. For this reason, we have de-
vised two different solutions to this shortcoming.
In the first place, we have munged a great num-
ber of our primary entities, in a way similar to that
described in Sa´nchez-Leo´n (2019) for gazetteers
used for protected information anonymization in
clinical texts. We basically transform canonical
forms in other possible textual forms observed
when working with biomedical texts. With such
transformations, a system module converts a salt
compound like clorhidrato de ciclopentolato into
ciclopentolato clorhidrato, or simply the PP de
potasio into its corresponding adjective pota´sico.
Other, more complex conversions include the
treatment of antibodies —for instance anticuerpo
contra especie de Leishmania becomes ac. Leish-
6Note that 2 of the PCR occurrences in the train+dev
datasets have been incorrectly mapped to the protein interpre-
tation (file S1130-63432014000100012-1, 2 times).
7Again, one of the occurrences of Cr has been
incorrectly mapped to the former extended form (file
S0212-16112012000500042-1).
mania, among other variants—, or pairs of antibi-
otics normally prescribed together —which have
a unique sctid and whose order we handle just as
the ‘glueing’ characters. Note, incidentally, that,
while the input to this pre-processing step is al-
ways a string, the output can be a regular expres-
sion, that is linked to a sctid. Plural forms are also
generated through this module, that uses 45 trans-
formations (not all equally productive). Using
these transformation rules, we produce 139,150
‘secondary entities’, many of them regexps. As
a final (simple) example of this, consider the en-
tity antı´geno CD13: after applying one of the pre-
vious string-to-regexp transformations, it is con-
verted to:
(?:antı´geno )?CD[- ]?13
With the previous regexp, the system is able
to identify (and string-normalize) six different
textual realizations of the same unique SNOMED
CT term. There are more complex rules that,
thus, produce many more potential strings. The
important thing with this strategy is that through
the generative power of these predictably-created
regexps from SNOMED CT entities the system is
able to improve its recall and overcome the limi-
tations of traditional dictionary-based approaches.
Secondly, to tackle with careless drafting
of clinical reports, a Levenshtein edit distance
library8 is used on the whole background dataset.
The process is run once, using our secondary enti-
ties as lexicon9 and a general vocabulary lexicon
to rule out common words in the candidate search
process. We have used distances in the range 1-3
(depending on string length) for sequences up to
8We use Text::Levensthtein::Flexible
library, from Perl ecosystem. One of the anonymous
reviewers has shed doubts about the use of Perl as a
language for “NLP and text-mining nowadays”. In this
respect, we are not committed with a given programming
language more than we are with our native language —and
we have submitted our paper in English, a foreign language
for us. The system could have been implemented in any other
programming language more popular “nowadays”, provided
that we were as proficient in it as we are in Perl and the
language used were as efficient in string and regexp handling
and in I/O operations as Perl is. In this regard, the most
popular language nowadays —Python— is 2 to 10 times
slower for these particular features. Perl is even faster for
regexp processing than Python PyPy —see, for instance,
https://github.com/mariomka/regex-benchmark.
Idiomatic Perl is even faster. Finally, Perl has a long
tradition in biology and medicine text processing.
9With enumeration of strings from non-infinite-loop reg-
exps.
3 words long10. The output of this process, which
links forms with spelling errors with canonical
ones and, thus, to sctids, can be inspected prior to
its inclusion in the system lexicon, if so desired.
3.1 Annotation process
As such, the annotation process is very simple.
The program reads the input byte stream trying to
identify known entities by means of a huge reg-
exp built through the pre-processing of the avail-
able resources. If the candidate entity is ambigu-
ous and (at least) one contextual rule exists for
it, it is applied. For the rest of the NEs, the sys-
tem assigns them the class and sctid found in our
ranked in-memory lexicon. As already mentioned
in passing, the system does not tokenize text prior
to NER, a processing order that we consider the
right choice for highly entity-dense texts. The
data structures built during pre-processing are ef-
ficiently stored on disk for subsequent runs, so the
pre-processing is redone only when resources are
edited.
4 Results
According to the organizers, and taking into ac-
count the HA of the tiny subset from the back-
ground dataset released to the participants11 , the
system obtained the scores presented in table 1,
ranking as second best system for subtask1 and
best system for subtask2 (Gonzalez-Agirre et al.,
2019).12.
Our results are consistent with our poor under-
standing of the classes for subtask 1. Having a
null knowledge of Pharmacology, Biomedicine or
even Chemistry, assigning classes (as requested
for subtask 1) to entities is very hard, while
10These words are not isolated from the byte stream, and
the process uses textual anchors to delimit them as word can-
didates. Consequently, no proper tokenization is performed.
11When compared with the rest of the tasks in BioNLP-
OST 2019, the time given to PHARMACONER participants to
submit their system runs is 4 times longer than the mean —
longer time that is unnecessary if system is mature enough.
On the other hand, the dataset released for evaluation pur-
poses is more than 4 times larger than the mean. As a con-
sequence, participating groups have to annotate full domain
corpora rather than just test dataset(s). A shorter submission
period and a smaller test dataset would be preferable, and be-
sides fairer, in future calls.
12The authors have been unable to obtain these
results with the official script, downloaded from
https://github.com/PlanTL-SANIDAD/PharmaCoNER-CODALAB-Evaluation-Script.
In their execution of the evaluation script, system results are
better (?).
Precision Recall F1-score
Subtask 1 0.90625 0.91314 0.90968
Subtask 2 0.91108 0.92083 0.91593
Table 1: Results for PHARMACONER test dataset (both
subtasks)
providing a sctid (subtask 2) seems an easier goal.
We will explain the point with an example entity
—a´cido hialuro´nico (‘hyaluronic acid’). Using
the ontological structure of SNOMED CT, one
can find the following parent relations (just in
English):
hyaluronic acid IS-A mucopolysaccharide
IS-A protein
The authors have, in this case, promoted the
PROTEINAS annotation for this entity, disre-
garding its interpretation as a replacement agent
and overlooking a recommendation on polysac-
charides in the AnnotGuide. Fortunately, all its
interpretations share a unique sctid. The same may
be true for
haemosiderin IS-A protein
which is considered NORMALIZABLE in the test
dataset. Similar cases are responsible for the
lower performance on subtask 1 with respect to
the more complex subtask 2.
In spite of these human classification errors,
our system scores outperform those obtained by
PharmacoNER Tagger13 (Armengol-Estape´ et al.,
2019), a simpler system using a binary classifica-
tion and a very different organization of the dataset
with a smaller fragment for test (10% of the data
as opposed to 25% for the official competition). In
fact, our system improves their F1-score (89.06)
by 1.3 points when compared with our results for
the more complex PHARMACONER subtask 1.
5 Discussion
In this section, we perform error analysis for our
system run on the test dataset. We will address
both recall and precision errors, but mainly
concentrate on the latter type, and on a thorough
13The tagger authors, some of them also organizers of
shared task, have changed the casing of the name for the pro-
gram.
revision of mismatches between system and
human annotations.
In general, error analysis is favoured by
knowledge-based methods, since it is through the
understanding of the underlying reasons for an er-
ror that the system could be improved. More-
over, and differently to what happens with the
current wave of artificial neural network methods,
the whole annotation process —its guidelines for
human annotators, the collection and appropriate
structuring of resources, the adequate means to as-
sign tags to certain entities but not to other, simi-
lar or even pertaining to the same class— must be
clearly understood by the designer/developer/data
architect of such systems. As a natural conse-
quence of this attempt to mimick a task defined
by humans to be performed, in the first place, also
by humans, some inconsistencies, asystematic or
missing assignments can be discovered, and this
information is a valuable treasure not only for sys-
tem developers but also for task organizers, guide-
line editors and future annotation campaigns, not
to mention for the exactness of program evaluation
results.
Most of the error types made by the system (i.e.,
by the authors) in class assignment for subtask 1
have already been discussed. In the same vein, as
regards subtask 2, a great number of errors come
from the selection of the ‘product containing sub-
stance’ reading from SNOMED CT rather to the
‘substance’ itself. This is due to inexperience of
the authors on the domain and the wrong consider-
ation of context when tagging entities —the latter
being clearly obviated in the AnnotGuide.
In the following paragraphs, some of the most
relevant inconsistencies found when performing
error analysis of our system are highlighted. The
list is necessarily incomplete due to space con-
straints, and it is geared towards the explanation
of our possible errors.
5.1 Inconsistency in the AG
Among some of the paradoxical examples in the
AnnotGuide it stands out the double explicit con-
sideration of gen (‘gene’), when occurs alone in
context, as both an entity to be tagged (positive
rule P2 of the AnnotGuide) and a noun not to be
tagged (negative rule N2). This inconsistency (and
a bit of bad luck) has produced that none of the
6 occurrences as an independent noun —not in-
troducing an entity— is tagged in the train+dev
(henceforth, t+d) while the only 2 in the same con-
text in the test dataset have been tagged. This
amounts for 2 true negatives (TNs) for the evalu-
ation script.
5.2 Inconsistency in HA as regards AG
The AnnotGuide proposal for the treatment of el-
liptical elements is somewhat confusing. For these
cases, a longest match annotation is proposed,
which is difficult to replicate automatically and
not easy to remember for the human annotator. In
many contexts, the annotator has made the right
choice —for instance, in receptores de estro´geno
y de progesterona— whereas in others do not —
|anticuerpos anticardiolipina| |IgG| e |IgM|, with
‘|’ marking the edges of the annotations. The last
example occurs twice in the test dataset. Hence,
the disagreement counts as 6 TNs and 2 false pos-
itives (FPs)14.
On the other hand, there is a clear reference to
food materials and nutrition in the AnnotGuide,
where they are included in the class of substances.
However, none of the following entities is tagged
in the test dataset: azu´car (which is mandatory
according to AnnotGuide and was tagged in t+d;
1 FP); almido´n de maı´z (also mandatory in An-
notGuide; 1 FP); and Loprofı´n, Aglutella, Aproten
(hypoproteic nutrition products, 3 FPs in total)15.
There is an explicit indication in the Annot-
Guide to annotate salts, with the example iron
salts. However, in the context sales de litio
(‘lithium salts’), only the chemical element has
been tagged (1 FP16).
There exist other differing-span mismatches be-
tween human and automatic annotation. These
include anticuerpos anticitoplasma de neutro´filo,
where the HA considers the first two words only (in
one of the occurrences, 1 FP); in the text fragment
b2 microglobulina, CEA y CA 19,9 normales, CA
19,9 is the correct span for the last entity (and not
CA, 1 FP); A.S.T is the span selected (for A.S.T., 1
FP); finally, in the context lgM anticore only lgM
has been tagged (1 FP).
Other prominent mismatch between HAD and
AnnotGuide is that of DNA, which is explicitly
14When we indicate this kind of information, mostly us-
ing only FPs, it must be understood that the system made the
choice(s) that the authors judge as correct, although disagree-
ing with HA and/or AnnotGuide.
15On nutrition replacements, see also section 5.3.
16Note, in passing, that these span errors account for 1 TN
also for the evaluation scripts.
included in the AnnotGuide (sects. P2 and O1). It
accounts for 2 FPs.
But perhaps one of the most common discrep-
ancies between human and automatic annotation
has to do with medicaments normally prescribed
together, which have a unique sctid. Examples in-
clude amiloride/hidroclorotiazida (1 FP); and be-
tametasona + calcipotriol (1 FP) in the test set.
This situation was also observed in the t+d cor-
pus fragment (tenofovir + emtricitabina, carbo-
nato ca´lcico /colecalciferol, lopinavir/ritonavir).
5.3 Inconsistency in HA on the test set as
regards t+d sets
Some inconsistencies between dataset annotations
have turned the authors crazy: NPT (acronym
for ‘total parenteral nutrition, TPN’) is tagged in
the train+dev dataset 15 out of 21 times it oc-
curs17. The common sense of frequency in the
HA of texts has led us to tag it in the background
set. Unluckily, neither NPT nor its expansion have
been tagged in the test dataset. This has also
been the behaviour in HA for ‘parenteral nutrition’
and ‘enteral nutrition’ (and their corresponding
acronyms) in test dataset, since these entities have
not been tagged. We asked the organizers about
this and other entities for which we had doubts,
either because the AnnotGuide didn’t cover their
cases or because the HA didn’t match the recom-
mendations in the AnnotGuide. Woefully, com-
munication with the organizers has not been very
fluent on this respect. All in all, this bad deci-
sion on the part of the authors amounts for 6 FPs
(more than 7.5% of our FPs according to evalua-
tion script).
For other cases, decisions that may be clearly
induced from the tagging of train+dev datasets,
have not been applied in the test corpus fragment.
These include cadenas ligeras (5 times in t+d, 1 FP
in test); enzimas hepa´ticas (tagged systematically
in t+d, 1 FP); p53 (also tagged in t+d, 1 FP).
Another entity that stands out is hidratos de car-
bono (‘carbohydrates’). It is tagged twice in the
t+d dataset, occurring 4 times in the set (once as
HC). However, although the form carbohidratos
has been annotated twice in the test set, hidratos
de carbono has been not (1 FP).
Moreover, suero (‘Sodium chloride solution’ or
17However, at least one expanded variant of it —nutricio´n
parenteral, ‘parenteral nutrition’— is never tagged.
‘serum’) deserves its own comment. Both entity
references are tagged in the train+dev datasets (al-
though with the latter meaning it is tagged only 4
out of 12 occurrences). We decided to tag it due to
its relevance. In the test dataset, it occurs 5 times
with the blood material meaning, but it has only
been tagged twice as such (one of them being an
error, since it refers to the former meaning). Our
system tagged all occurrences, but tagged also one
of the instances with the former meaning as serum
(3 FPs).
Finally, there are some inconsistencies within
the same dataset. For example, nutricional agent
Kabiven is tagged as both NORMALIZABLES
(with sctid) and NO NORMALIZABLES in the very
same text. The same happens with another nu-
tritional complement, Cernebit, this time in two
different files. The perfusion solution Isoplasmal
G (with a typo in the datasets —Isoplasmar G)
is tagged as NORMALIZABLES and UNCLEAR.
These examples reveal a vague understanding (or
definition) of criteria as regards fluids and nutri-
tion, as we pointed out at the beginning of this
section.
5.4 Asystematic/incomplete annotation
Some of the entities occurring in the test dataset
have not always been tagged. This is the case
for celulosa (annotated only once but used twice,
1 FP); vimentina (same situation as previous, 1
FP); LDH (tagged 20 times in t+d but not in one
of the files, 1 FP); cimetidina (1 FP); reactantes
de fase aguda (2 FPs; 2 other occurrences were
tagged); anticuerpos antinucleares (human anno-
tators missed 1, considered FP).
5.5 Incorrect sctids
On our refinement work with the system, some in-
correct sctids have emerged. These errors impact
on subtask 2 (some also on subtask 1). A large
sample of them is enumerated below.
ARP (‘actividad de renina plasma´tica’, ‘plasma
renin activity’, PRA) cannot be linked to sctid for
renina, which happens twice. In the context ‘perfil
de antigenos [sic] extraı´bles del nu´cleo (ENA)’,
ENA has been tagged with sctid of the antibody
(1 FP). In one of the files, tioflavina is linked to
sctid of tioflavina T, but it could be tioflavina S.
Thus, it should be NO NORMALIZABLE.Harvoni
is ChEBI:85082 and not <null> (1 FP). AcIgM
contra CMV has a wrong sctid (1 FP). HBsAg
has no sctid in the test set; it should be 22290004
(‘Hepatitis B surface antigen’) (1 FP).
There are other incorrect annotations, due to
inadvertent human errors, like biotina tagged
as PROTEINAS or VEB (‘Epstein-Barr virus’)
being annotated when it is not a substance.
Among these mismatches between HA and system
annotation, the most remarkable is the case of
synonyms in active principles. For instance,
the brand name drug Dekapine has been linked
to ‘a´cido valproico’ in the former case and to
‘valproato so´dico’ in the latter. These terms are
synonymous18, but sadly they don’t share sctid.
Hence, this case also counts as a FP.
A gold standard dataset for any task is very
hard to develop, so a continuous editing of it is
a must19. In this discussion, we have focused on
false positives (FPs) according to the script used
for system evaluation, with the main purpose of
understanding the domain knowledge encoded in
the linguistic conventions (lexical/terminological
items and constructions) used by health profes-
sionals, but also the decisions underlying both the
AnnotGuide and the HA practice.
In this journey to system improvement and au-
thors enlightenment, some inconsistencies, errors,
omissions have come up, as it has been reflected
in this section, so both the guidelines for and the
practice of annotation can also be improved in fu-
ture use scenarios of the clinical case corpus built
and maintained by the shared task organizers.
Our conclusion on this state of affairs is that
some of the inconsistencies spotted in this sec-
tion show that there were not a rational approach
to the annotation of certain entities contained in
the datasets (apart from other errors and/or over-
sights), and, hence, the upper bound of any tag-
ging system is far below the ideal 1.0 F1-score. To
this respect, in very many cases, the authors have
made the wrong choice, but in others they were
guided by analogy or common sense. Maybe a se-
lection founded on probability measures estimated
on training material could have obtained better re-
sults with this specific test dataset. However, in the
18Although, ‘valproato so´dico’ is the name used
in the leaflet, as it can be seen in the Span-
ish Medicament Agency, AEMPS, web page
(https://cima.aemps.es/cima/dochtml/p/48828/P_48828.html:
last consulted on 16.07.2019).
19Besides, when the dataset is being used in a shared task,
this refinement process should be available to participants
while the task is open.
end, this cannot be considered as an indication of
a better system performance, since, as it has been
shown, the test dataset used still needs more re-
finement work to be used as the right dataset for
automatic annotation evaluation.
6 Conclusions
With this resource-based system developed for the
PHARMACONER shared task on NER of pharmaco-
logical, chemical and biomedical entities, we have
demonstrated that, having a very limited knowl-
edge of the domain, and, thus, making wrong
choices many times in the creation of resources
for the tasks at hand, but being more flexible with
the matching mechanisms, a simple-design system
can outperform a NER tagger for biomedical enti-
ties based on state-of-the-art artificial neural net-
work technology. Thus, knowledge-based meth-
ods stand on their own merits in task resolution.
But, perhaps most importantly, the other key
point brought to light in this contribution is that a
resource-based approach also favours a more crit-
ical stance on the dataset(s) used to evaluate sys-
tem performance. With these methods, system de-
velopment can go hand in hand with dataset re-
finement in a virtuous circle that let us think that
maybe next time we are planning to add a new
gazetteer or word embedding to our system in
order to try to improve system performance, we
should first look at our data and, like King Mi-
das, turn our Human Annotated Dataset into a true
Gold Standard Dataset.
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